{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:58:34Z","timestamp":1791910714376,"version":"4.3.4"},"reference-count":6,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"published-print":{"date-parts":[[2004,3]]},"abstract":"<jats:p>Adverse reactions to medication are well recognised although information on the incidence in children is lacking. Adverse reactions have also been attributed to a range of pharmaceutical excipients. This is a report of an adverse reaction to the excipient in clindamycin injection.<\/jats:p>","DOI":"10.1136\/adc.2002.024927","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T15:10:45Z","timestamp":1082387445000},"page":"F184-F184","source":"Crossref","is-referenced-by-count":27,"title":["Probable adverse reaction to a pharmaceutical excipient"],"prefix":"10.1136","volume":"89","author":[{"given":"C M","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D W A","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Berrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2004,3,1]]},"reference":[{"key":"2025090514572091000_89.2.F184.1","unstructured":"Pharmacia. Summary of product characteristics: Dalacin C phosphate injection. Pharmacia Ltd, UK."},{"key":"2025090514572091000_89.2.F184.2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJM198211253072206","volume":"307","year":"1982","journal-title":"N Engl J Med"},{"key":"2025090514572091000_89.2.F184.3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.77.4.500","volume":"77","year":"1986","journal-title":"Pediatrics"},{"key":"2025090514572091000_89.2.F184.4","unstructured":"American Academy of Pediatrics Committee on Drugs. \u00e2\u0080\u009cInactive\u00e2\u0080\u009d ingredients in pharmaceutical products: update (subject review). http:\/\/www.aap.org\/policy\/re9706.html."},{"key":"2025090514572091000_89.2.F184.5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00128072-200204060-00004","volume":"4","year":"2002","journal-title":"Pediatr Drugs"},{"key":"2025090514572091000_89.2.F184.6","doi-asserted-by":"crossref","unstructured":"Moore TJ, Weiss SR, Kaplan S, et al. Reported adverse drug events in infants and children under 2 years of age. http:\/\/www.pediatrics.org\/cgi\/content\/full\/110\/5\/e53.","DOI":"10.1542\/peds.110.5.e53"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.2002.024927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T22:27:49Z","timestamp":1757111269000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/adc.2002.024927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":6,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2004,3,1]]},"published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1136\/adc.2002.024927"],"URL":"https:\/\/doi.org\/10.1136\/adc.2002.024927","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}